Stay updated on Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.

Latest updates to the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page
- Check3 days agoChange DetectedThe study record history now shows a Returned: 2026-06-30 entry with Quality Control Review Has Not Concluded and adds new sections such as More Information, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and Document Section under Study Status. It also updates the record to Revision: v3.6.3 from v3.6.2.SummaryDifference0.6%

- Check10 days agoChange DetectedThe page now shows Revision: v3.6.2 in the footer, replacing the previous v3.6.0. This reflects a new site build/version without changing study history content.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe history updates indicate that recruitment has ceased and that results have been submitted. The record has been revised to version 3.6.0, replacing the prior 3.5.5 and removing the 'No Results Posted' note.SummaryDifference0.2%

- Check32 days agoChange DetectedA new site revision tag (v3.5.5) was added to the page history, replacing the previous revision (v3.5.4). This indicates a minor software update to the page rather than substantive content changes.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page history shows a new Revision: v3.5.4, indicating a new build/version of the page. The modification is limited to metadata and does not alter the study details displayed.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page’s displayed UI/application revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version tweak rather than a change to the trial record itself.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.